# FDA Inspection 1192553 - Linical Accelovance America, Inc. - November 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/linical-accelovance-america-inc/f8f8c68d-93f9-42a3-8bad-278c4e9f5d37
Source feed: FDA_Inspections

> FDA Inspection 1192553 for Linical Accelovance America, Inc. on November 17, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192553
- Company Name: Linical Accelovance America, Inc.
- Inspection Date: 2022-11-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/linical-accelovance-america-inc/0a8522ff-88ad-43da-93a8-cb645e4f0275

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c